In a significant development for respiratory healthcare in the United Kingdom, the National Institute for Health and Care Excellence (NICE)…
Read More
Expanding Screening for Type 1 Diabetes in Children Could Identify More Cases
A significant shift in the approach to identifying type 1 diabetes in children is being advocated for, with a new…
Read More
FDA Approves Langlara, an Interchangeable Biosimilar for Diabetes Management, Expanding Patient Access and Treatment Options
Sunshine Lake Pharma, Lannett Company, and its wholly owned subsidiary Lanexa Biologics have achieved a significant milestone in diabetes care…
Read More
The Crucial Role of Payload Linker Innovation in the Rapidly Expanding Antibody-Drug Conjugate Market
Combining the targeted precision of monoclonal antibodies with the potent destructive power of cytotoxic payloads, Antibody-Drug Conjugates (ADCs) represent a…
Read MoreYOU MAY HAVE MISSED
